Clinical Trial Update: Avatrombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating avatrombopag for chemotherapy-induced thrombocytopenia is currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Chemotherapy-induced Thrombocytopenia, Avatrombopag | Phase 2 | Status: RECRUITING